CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the ...
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
Once a vaccine is brewed, simply ship patches to people's homes with instructions to slap one on. Doctors might not like the go-it-alone method. But the technology's main promise may be in developing ...
Many kids are scared of getting needles, and this can stop them getting vaccinations that protect that against the flu. Less than one in four Australian children were vaccinated against influenza in ...
Scientists have developed a nasal vaccine to protect against bird flu. The corresponding study was published in Cell Reports Medicine. "Our vaccine to the nose and upper airway -- not the ...
Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...
French drug company Sanofi announced it's discontinuing research and development for its next-generation mRNA flu vaccine. The company shared the news in an earnings document, saying it was ending the ...
Add Yahoo as a preferred source to see more of our stories on Google. HHS Secretary Robert F. Kennedy Jr., speaks at an event where Secretary of Agriculture Brooke Rollins signed SNAP food choice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results